Breast Cancer
Articles and resources on breast cancer for patients, caregivers, and family members
Ricki Fairley was told she had 2 years to live. That was 8 years ago. This is her inspiring story of survival. Read More ›
Your nurse navigator is the key person on your healthcare team to connect with throughout the entire course of your experience. Here’s why. Read More ›
Welcome to our newest issue of CONQUER. We know the value of hearing the experiences of cancer survivors and family caregivers. It helps people to relate, feel a sense of connection, and provides food for thought. We have many stories, with several focusing on breast cancer, including male breast cancer. Pink ribbons are not just for women. Read More ›
Recently, Tecentriq became the first immunotherapy to be approved for the treatment of patients with metastatic triple-negative breast cancer, a particularly difficult type of breast cancer. Read More ›
Enjoy Lillie Shockney’s sense of humor as you read her personal story of how working as a nurse and facing her own breast cancer diagnosis shaped her life and her lifelong work as a breast cancer educator and advocate. Read More ›
By Teresa Todt
Teresa Todt could not shake the nagging feeling that the pain in her breast was something serious, but repeated visits to her gynecologist and a mammogram didn’t lead anywhere. It was only after she found blood in her bra that additional tests showed she had invasive breast cancer. Read More ›
Samantha Anderson refused to give up when her triple-negative breast cancer returned. Trusting her oncologist, she enrolled in the clinical trial with Tecentriq (atezolizumab) that led to the approval of the first immunotherapy for this type of breast cancer. Read More ›
Triple-negative breast cancer is an aggressive type of cancer that usually has a high rate of disease recurrence (returning) within the first 5 years after diagnosis. Read More ›
If you have been told you have metastatic breast cancer, make sure you understand what that means. Where did the cancer travel? Read More ›





